CGEM vs RUN · $830.3M cap vs P/E 6.0, rev $2.04B
Cullinan Oncology LLC (CGEM) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
CGEM currently screens at market cap $830.3M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the CGEM and RUN stock pages for the full models.
Not investment advice.